Vicore Pharma Holding AB
Limited financial coverage for VCRE.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.
- CEO
- Ahmed Mousa
- IPO
- 2026
- Employees
- 40
- HQ
- Stockholm, AB, SE
Get TickerSpark's AI analysis on VCRE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- 52W High
- $17.80
- 52W Low
- $11.00
- 50D MA
- $12.77
- 200D MA
- $12.77
- Beta
- 0.15
- RSI (14)
- 6
- Avg Volume
- 59.49K
No earnings-call transcripts are available for VCRE yet.
- Free Float
- 70.6%
- Shares Outstanding
- 281.53M
- Float Shares
- 198.62M
Our VCRE coverage
Recent articles, reports, and earnings notes.
Want a deeper read on VCRE?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Bullish or bearish?
Where do you stand on VCRE?